Literature DB >> 18646564

Molecular etiology of idiopathic cardiomyopathy.

T Arimura1, T Hayashi, A Kimura.   

Abstract

Idiopathic cardiomyopathy (ICM) is a primary cardiac disorder associated with abnormalities of ventricular wall thickness, size of ventricular cavity, contraction, relaxation, conduction and rhythm. Over the past two decades, molecular genetic analyses have revealed that mutations in the various genes cause ICM and such information concerning the genetic basis of ICM enables us to speculate the pathogenesis of this heterogeous cardiac disease. This review focuses on the molecular pathogenesis, i.e., genetic abnormalities and functional alterations due to the mutations especially in sarcomere/cytoskeletal components, in three characteristic features of ICM, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). Understanding the functional abnormalities of the sarcomere/cytoskeletal components, in ICM, has unraveled the function of these components not only as a contractile unit but also as a pivot for transduction of biochemical signals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18646564      PMCID: PMC2949306     

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  34 in total

1.  Converging pathways and principles in heart development and disease: CV@CSH.

Authors:  Kenneth R Chien; Eric N Olson
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

2.  Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac myocytes.

Authors:  O Cazorla; Y Wu; T C Irving; H Granzier
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

3.  Subcellular targeting of metabolic enzymes to titin in heart muscle may be mediated by DRAL/FHL-2.

Authors:  Stephan Lange; Daniel Auerbach; Patricia McLoughlin; Evelyne Perriard; Beat W Schäfer; Jean-Claude Perriard; Elisabeth Ehler
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

4.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene.

Authors:  M Satoh; M Takahashi; T Sakamoto; M Hiroe; F Marumo; A Kimura
Journal:  Biochem Biophys Res Commun       Date:  1999-08-27       Impact factor: 3.575

5.  Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.

Authors:  S Morimoto; Q-W Lu; K Harada; F Takahashi-Yanaga; R Minakami; M Ohta; T Sasaguri; I Ohtsuki
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

6.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Authors:  Jens Mogensen; Toru Kubo; Mauricio Duque; William Uribe; Anthony Shaw; Ross Murphy; Juan R Gimeno; Perry Elliott; William J McKenna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

7.  Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.

Authors:  Bhagyalaxmi Mohapatra; Shinawe Jimenez; Jiuann Huey Lin; Karla R Bowles; Karen J Coveler; Joseph G Marx; Michele A Chrisco; Ross T Murphy; Paul R Lurie; Robert J Schwartz; Perry M Elliott; Matteo Vatta; William McKenna; Jeffrey A Towbin; Neil E Bowles
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

8.  Alterations in thin filament regulation induced by a human cardiac troponin T mutant that causes dilated cardiomyopathy are distinct from those induced by troponin T mutants that cause hypertrophic cardiomyopathy.

Authors:  Paul Robinson; Mahmooda Mirza; Adam Knott; Hassan Abdulrazzak; Ruth Willott; Steven Marston; Hugh Watkins; Charles Redwood
Journal:  J Biol Chem       Date:  2002-08-18       Impact factor: 5.157

9.  The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy.

Authors:  Ralph Knöll; Masahiko Hoshijima; Hal M Hoffman; Veronika Person; Ilka Lorenzen-Schmidt; Marie-Louise Bang; Takeharu Hayashi; Nobuyuki Shiga; Hideo Yasukawa; Wolfgang Schaper; William McKenna; Mitsuhiro Yokoyama; Nicholas J Schork; Jeffrey H Omens; Andrew D McCulloch; Akinori Kimura; Carol C Gregorio; Wolfgang Poller; Jutta Schaper; Heinz P Schultheiss; Kenneth R Chien
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

10.  Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly.

Authors:  P Young; E Ehler; M Gautel
Journal:  J Cell Biol       Date:  2001-07-09       Impact factor: 10.539

View more
  4 in total

Review 1.  Titin mutations: the fall of Goliath.

Authors:  Manuel Neiva-Sousa; João Almeida-Coelho; Inês Falcão-Pires; Adelino F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2015-09       Impact factor: 4.214

2.  Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy.

Authors:  Dilek Colak; Namik Kaya; Jawaher Al-Zahrani; Albandary Al Bakheet; Paul Muiya; Editha Andres; John Quackenbush; Nduna Dzimiri
Journal:  Genomics       Date:  2009-03-28       Impact factor: 5.736

3.  Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy.

Authors:  Dilek Colak; Ayodele A Alaiya; Namik Kaya; Nzioka P Muiya; Olfat AlHarazi; Zakia Shinwari; Editha Andres; Nduna Dzimiri
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

4.  Pigs with δ-sarcoglycan deficiency exhibit traits of genetic cardiomyopathy.

Authors:  Hitomi Matsunari; Michiyo Honda; Masahito Watanabe; Satsuki Fukushima; Kouta Suzuki; Shigeru Miyagawa; Kazuaki Nakano; Kazuhiro Umeyama; Ayuko Uchikura; Kazutoshi Okamoto; Masaki Nagaya; Teruhiko Toyo-Oka; Yoshiki Sawa; Hiroshi Nagashima
Journal:  Lab Invest       Date:  2020-02-14       Impact factor: 5.662

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.